A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis - A phase I clinical trial

Thurau, Stephan; Deuter, Christoph M. E.; Heiligenhaus, Arnd; Pleyer, Uwe; Van Calster, Joachim; Barisani-Asenbauer, Talin; Obermayr, Franz; Sperl, Stefan; Seda-Zehetner, Romana; Wildner, Gerhild

dc.contributor.author	Deuter, Christoph M.E.
dc.date.accessioned	2023-05-30T04:50:46Z
dc.date.available	2023-05-30T04:50:46Z
dc.date.issued	2022
dc.identifier.issn	2296-858X
dc.identifier.uri	http://hdl.handle.net/10900/141456
dc.language.iso	en	de_DE
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fmed.2022.1023224	de_DE
dc.subject.ddc	610	de_DE
dc.title	A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis - A phase I clinical trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_00861
utue.personen.roh	Thurau, Stephan
utue.personen.roh	Deuter, Christoph M. E.
utue.personen.roh	Heiligenhaus, Arnd
utue.personen.roh	Pleyer, Uwe
utue.personen.roh	Van Calster, Joachim
utue.personen.roh	Barisani-Asenbauer, Talin
utue.personen.roh	Obermayr, Franz
utue.personen.roh	Sperl, Stefan
utue.personen.roh	Seda-Zehetner, Romana
utue.personen.roh	Wildner, Gerhild
dcterms.isPartOf.ZSTitelID	Frontiers in Medicine	de_DE
dcterms.isPartOf.ZS-Issue	Article 1023224	de_DE
dcterms.isPartOf.ZS-Volume	9	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE